CIA
IMMU

Capital Impact Advisors’s Immunomedics Inc IMMU Stock Holding History

Capital Impact Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-43,323
Closed -$208K – 318
2014
Q4 		$208K Hold
43,323
– – 0.1% 110
2014
Q3 		$161 Hold
43,323
– – ﹤0.01% 121
2014
Q2 		$158K Buy
+43,323
New +$159K 0.12% 179

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Impact Advisors's IMMU Position: Q1 2015 in Review

Capital Impact Advisors sold out of Immunomedics Inc (IMMU) in Q1 2015, closing a stake of 43,323 shares — an estimated $208K sold.

Capital Impact Advisors first reported a position in IMMU in Q2 2014 and held it in 3 quarters. The position peaked at $208K in Q4 2014. 86 funds tracked by Wall St. Rank hold IMMU as of Q1 2015.

  • Capital Impact Advisors reported no remaining Immunomedics Inc position as of Q1 2015 after selling out during the quarter.
  • Capital Impact Advisors sold 43,323 Immunomedics Inc shares in Q1 2015, an estimated $208K.
  • Capital Impact Advisors first reported a position in Immunomedics Inc in Q2 2014 and held it in 3 quarters.
  • Capital Impact Advisors's Immunomedics Inc position peaked at $208K in Q4 2014.
  • 86 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2015.

Based on Capital Impact Advisors's 13F filing for Q1 2015, filed 29 May 2015.